A Pilot Collaborative Study to Improve the Diagnosis and Treatment of Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma in Senegal: The LYMPHODAK Study.

Fiche publication

Date publication

août 2025

Journal

EJHaem

Auteurs

Membres identifiés du Cancéropôle Est :
Pr FEUGIER Pierre

Tous les auteurs :
Diop S, Moulin C, Aïssatou Touré S, Gueye SM, Deltour S, Diop Y, Ndiaye FS, Dial MC, Sartelet H, Seck M, Fall S, Senghor AB, Touré AO, Faye BF, Bousso ES, Diallo AB, Keita M, Niang ED, Dieng N, Vigneron J, Thieblemont C, Lévy V, Raphael M, Feugier P

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/40801054

Résumé

Management of diffuse large B-cell lymphoma (DLBCL) in Africa is hampered by limited access to diagnosis and treatment, due to the small number of haematopathologists and lack of clear healthcare pathway. A cooperation between France and Senegal was established to improve diagnosis and provide access to the standard-of-care (R-CHOP) to patients with DLBCL in Dakar.